Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort

Increased eligibility for statin therapy impacts large proportions of the present population and healthcare budgets. Decisions to take and reimburse statins should be considered on the basis of expected cost-effectiveness and acceptability to patients.